Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

Jens Overgaard; Hanne Sand Hansen; Lena Specht; Marie Overgaard; Cai Grau; Elo Andersen; Jens Knud Daugaard Bentzen; Lars Bastholt; Olfred Hansen; Jørgen Johansen; Lisbeth Andersen; Jan F Evensen

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

Jens Overgaard, Hanne Sand Hansen, Lena Specht, Marie Overgaard, Cai Grau, Elo Andersen, Jens Knud Daugaard Bentzen, Lars Bastholt, Olfred Hansen, Jørgen Johansen, Lisbeth Andersen, Jan F Evensen

Department of Oncology

653 Citations (Scopus)

Abstract

Although head and neck cancer can be cured by radiotherapy, the optimum treatment time for locoregional control is unclear. We aimed to find out whether shortening of treatment time by use of six instead of five radiotherapy fractions per week improves the tumour response in squamous-cell carcinoma.

Original language	English
Journal	Lancet
Volume	362
Issue number	9388
Pages (from-to)	933-40
Number of pages	8
ISSN	0140-6736
Publication status	Published - 20 Sept 2003

Cite this

@article{73615f21e8df48419803c911ca081c4e,

title = "Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial",

abstract = "Although head and neck cancer can be cured by radiotherapy, the optimum treatment time for locoregional control is unclear. We aimed to find out whether shortening of treatment time by use of six instead of five radiotherapy fractions per week improves the tumour response in squamous-cell carcinoma.",

author = "Jens Overgaard and Hansen, \{Hanne Sand\} and Lena Specht and Marie Overgaard and Cai Grau and Elo Andersen and Bentzen, \{Jens Knud Daugaard\} and Lars Bastholt and Olfred Hansen and J{\o}rgen Johansen and Lisbeth Andersen and Evensen, \{Jan F\}",

year = "2003",

month = sep,

day = "20",

language = "English",

volume = "362",

pages = "933--40",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "9388",

}

TY - JOUR

T1 - Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

AU - Overgaard, Jens

AU - Hansen, Hanne Sand

AU - Specht, Lena

AU - Overgaard, Marie

AU - Grau, Cai

AU - Andersen, Elo

AU - Bentzen, Jens Knud Daugaard

AU - Bastholt, Lars

AU - Hansen, Olfred

AU - Johansen, Jørgen

AU - Andersen, Lisbeth

AU - Evensen, Jan F

PY - 2003/9/20

Y1 - 2003/9/20

N2 - Although head and neck cancer can be cured by radiotherapy, the optimum treatment time for locoregional control is unclear. We aimed to find out whether shortening of treatment time by use of six instead of five radiotherapy fractions per week improves the tumour response in squamous-cell carcinoma.

AB - Although head and neck cancer can be cured by radiotherapy, the optimum treatment time for locoregional control is unclear. We aimed to find out whether shortening of treatment time by use of six instead of five radiotherapy fractions per week improves the tumour response in squamous-cell carcinoma.

UR - https://www.scopus.com/pages/publications/0141540770

M3 - Journal article

C2 - 14511925

SN - 0140-6736

VL - 362

SP - 933

EP - 940

JO - Lancet

JF - Lancet

IS - 9388

ER -

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

Abstract

Other files and links

Fingerprint

Cite this